FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称AMPRENAVIR
异名/同义词(3S-(3R*(1R*,2S*)))-(3-(((4-AMINOPHENYL)SULFONYL)(2-METHYLPROPYL)AMINO)-2-HYDROXY-1-(PHENYLMETHYL)PROPYL) TETRAHYDRO-3-FURANYL CARBAMATE
(3S)-TETRAHYDRO-3-FURYL ((.ALPHA.S)-.ALPHA.-((1R-1-HYDROXY-2-(N1-ISOBUTYLSULFANILAMIDO)ETHYL)PHENETHYL)CARBAMATE
141W94
141W94
AGENERASE
AMPRENAVIR
AMPRENAVIR [EMA EPAR]
AMPRENAVIR [HSDB]
AMPRENAVIR [INN]
AMPRENAVIR [JAN]
AMPRENAVIR [MART.]
AMPRENAVIR [MI]
AMPRENAVIR [ORANGE BOOK]
AMPRENAVIR [USAN]
AMPRENAVIR [VANDF]
AMPRENAVIR [WHO-DD]
J05AE05
KVX-478
VX-478
CAS登记号161814-49-9
物质唯一标识(Unique Ingredient Identifier)5S0W860XNR
分子式C25H35N3O6S
国际化合物标识(International Chemical Identifier,InChI)YMARZQAQMVYCKC-OEMFJLHTSA-N
SMILESS(N(C[C@@H](O)[C@@H](NC(O[C@H]1CCOC1)=O)Cc2ccccc2)CC(C)C)(c3ccc(N)cc3)(=O)=O
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System